Skip to main content
Merck KGaA (MKGAF)
OTCMKTS · Delayed Price · Currency is USD
135.65
-2.40 (-1.74%)
Mar 31, 2025, 9:43 AM EST

Merck KGaA Revenue

In the year 2024, Merck KGaA had annual revenue of 21.16B EUR with 0.78% growth. Merck KGaA had revenue of 5.42B in the quarter ending December 31, 2024, with 3.69% growth.

Revenue
21.16B EUR
Revenue Growth
+0.78%
P/S Ratio
n/a
Revenue / Employee
358.45K EUR
Employees
59,020
Market Cap
59.49B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202421.16B163.00M0.78%
Dec 31, 202320.99B-1.24B-5.57%
Dec 31, 202222.23B2.55B12.93%
Dec 31, 202119.69B2.15B12.28%
Dec 31, 202017.53B1.38B8.56%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
SS Innovations International 16.04M
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
Northwest Biotherapeutics 1.60M
Silence Therapeutics 43.26M
American Oncology Network 1.76B
Revenue Rankings

Merck KGaA News

More News